ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.

ALLO Allogene Therapeutics Inc

2.3418
-0.1982 (-7.80%)
15 Jun 2024 - Closed
Delayed by 15 minutes

Allogene Therapeutics Financial Summary

The current ALLO market cap is 395.98M. The company's latest EPS is USD -1.9354 and P/E is -1.22.

Quarter End Mar 2023Jun 2023Sep 2023Dec 2023Mar 2024
USD (US$)USD (US$)USD (US$)USD (US$)USD (US$)
Total Revenue 52k44k43k-44k22k
Operating Income -99.07M-80.52M-62.98M-71.93M-69.5M
Net Income -98.7M-77.99M-61.32M-89.26M-65M
Year End 31 December 2023 20192020202120222023
USD (US$)USD (US$)USD (US$)USD (US$)USD (US$)
Total Revenue 0038.49M243k95k
Operating Income -202.01M-258.24M-255.79M-335.45M-314.49M
Net Income -184.59M-250.22M-257.01M-332.63M-327.27M
Quarter End Mar 2023Jun 2023Sep 2023Dec 2023Mar 2024
USD (US$)USD (US$)USD (US$)USD (US$)USD (US$)
Total Assets 746.87M770.97M712.33M642.84M586.35M
Total Liabilities 154.61M148.07M129.22M130.6M124.98M
Total Equity 592.26M622.91M583.1M512.23M461.37M
Year End 31 December 2023 20192020202120222023
USD (US$)USD (US$)USD (US$)USD (US$)USD (US$)
Total Assets 717.8M1.23B1.04B817.08M642.84M
Total Liabilities 88.78M148.21M122.23M151.21M130.6M
Total Equity 629.02M1.08B916.41M665.87M512.23M
Quarter End Mar 2023Jun 2023Sep 2023Dec 2023Mar 2024
USD (US$)USD (US$)USD (US$)USD (US$)USD (US$)
Operating -66.64M-128.5M-184.03M-237.73M-55.9M
Investing 112.94M130.1M95.83M163.29M22.13M
Financing 1.73M91.26M95.54M95.7M1.65M
Year End 31 December 2023 20192020202120222023
USD (US$)USD (US$)USD (US$)USD (US$)USD (US$)
Operating -137.35M-115.09M-184.81M-220.52M-237.73M
Investing 164.08M-505.12M163.66M106.16M163.29M
Financing 58.96M633.59M11.96M2.95M95.7M
Market Cap 395.98M
Price to Earnings Ratio -1.22
Price to Sales Ratio 3.93k
Price to Cash Ratio 4.8
Price to Book Ratio 0.78
Dividend Yield -

Share Statistics

Shares Outstanding 169.09M
Average Volume (1 week) 2.16M
Average Volume (1 Month) 2.89M
52 Week Change -57.81%
52 Week High 6.05
52 Week Low 2.23
Spread (Intraday) 1.28 (47.06%)

Company Info

Company Name Allogene Therapeutics Inc
Address 251 little falls drive
wilmington, delaware 19808
Website https://www.allogene.com
Industry biological pds,ex diagnstics (2836)